Top

Journal of Translational Medicine

Published in:

Open Access 01-12-2020 | Fatigue | Review

Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)

Authors: Eun-Jin Lim, Chang-Gue Son

Published in: Journal of Translational Medicine | Issue 1/2020

Abstract

Background

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a debilitating disease with unknown causes. From the perspectives on the etiology and pathophysiology, ME/CFS has been labeled differently, which influenced changes in case definitions and terminologies. This review sought to feature aspects of the history, developments, and differential symptoms in the case definitions.

Methods

A search was conducted through PubMed published to February 2020 using the following search keywords: case definition AND chronic fatigue syndrome [MeSH Terms]. All reference lists of the included studies were checked. Of the included studies, the number of citations and the visibility in the literatures of the definitions were considered for comparisons of the criteria.

Results

Since the first 'ME' case definition was developed in 1986, 25 case definitions/diagnostic criteria were created based on three conceptual factors (etiology, pathophysiology, and exclusionary disorders). These factors can be categorized into four categories (ME, ME/CFS, CFS, and SEID) and broadly characterized according to primary disorder (ME-viral, CFS-unknown, ME/CFS-inflammatory, SEID-multisystemic), compulsory symptoms (ME and ME/CFS-neuroinflammatory, CFS and SEID-fatigue and/or malaise), and required conditions (ME-infective agent, ME/CFS, CFS, SEID-symptoms associated with fatigue, e.g., duration of illness). ME and ME/CFS widely cover all symptom categories, while CFS mainly covers neurologic and neurocognitive symptoms. Fatigue, cognitive impairment, PEM, sleep disorder, and orthostatic intolerance were the overlapping symptoms of the 4 categories, which were included as SEID criteria.

Conclusions

This study comprehensively described the journey of the development of case definitions and compared the symptom criteria. This review provides broader insights and explanations to understand the complexity of ME/CFS for clinicians and researchers.

Available only for authorised users

Jason LA, Sunnquist M, Brown A, Evans M, Vernon SD, Furst J, et al. Examining case definition criteria for chronic fatigue syndrome and myalgic encephalomyelitis. Fatigue. 2014;2:40–56.PubMed

Osoba T, Pheby D, Gray S, Nacul L. The Development of an epidemiological definition for myalgic encephalomyelitis/chronic fatigue syndrome. J Chronic Fatigue Syndr. 2007;14:61–84.

American ME and CFS Society. How many people have ME/CFS? U.S. 2019. https://ammes.org/how-many-people-have-mecfs/. Accessed 31 Jan 2019.

Bethesda M. Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) research: workshop report. State of the knowledge workshop. National Institutes of Health. 2011. https://www.meassociation.org.uk/wp-content/uploads/2011/08/SoK-Workshop-Report-508-compliant-8-5-11.pdf. Accessed 25 Mar 2019.

Institute of Medicine. Beyond myalgic encephalomyelitis/chronic fatigue syndrome; Redefining an illness. Institute of medicine of the national academies. 2015. www.nap.edu. Accessed 12 Feb 2019.

Parish JG. Early outbreaks of 'epidemic neuromyasthenia'. Postgrad Med J. 1978;54:711–7.PubMedPubMedCentral

Wojcik W, Armstrong D, Kanaan R. Chronic fatigue syndrome: labels, meanings and consequences. J Psychosom Res. 2011;70:500–4.PubMed

Speight N. Myalgic encephalomyelitis/chronic fatigue syndrome: Review of history, clinical features, and controversies. Saudi J Med Med Sci. 2013;1:11–3.

Rowe PC, Underhill RA, Friedman KJ, Gurwitt A, Medow MS, Schwartz MS, et al. Myalgic encephalomyelitis/chronic fatigue syndrome diagnosis and management in young people: a primer. Front Pediatr. 2017;5:121.PubMedPubMedCentral

10.

Brurberg KG, Fonhus MS, Larun L, Flottorp S, Malterud K. Case definitions for chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME): a systematic review. BMJ open. 2014;4:e003973.PubMedPubMedCentral

11.

Christley Y, Duffy T, Martin CR. A review of the definitional criteria for chronic fatigue syndrome. J Eval Clin Pract. 2012;18:25–31.PubMed

12.

Bayliss K, Goodall M, Chisholm A, Fordham B, Chew-Graham C, Riste L, et al. Overcoming the barriers to the diagnosis and management of chronic fatigue syndrome/ME in primary care: a meta synthesis of qualitative studies. BMC Fam Pract. 2014;15:44.PubMedPubMedCentral

13.

Devasahayam A, Lawn T, Murphy M, White PD. Alternative diagnoses to chronic fatigue syndrome in referrals to a specialist service: service evaluation survey. JRSM Short Rep. 2012;3:4.PubMedPubMedCentral

14.

Nacul LC, Lacerda EM, Pheby D, Campion P, Molokhia M, Fayyaz S, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;9:91.PubMedPubMedCentral

15.

Lim EJ, Ahn YC, Jang ES, Lee SW, Lee SH, Son CG. Systematic review and meta-analysis of the prevalence of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Transl Med. 2020;18:100.PubMedPubMedCentral

16.

Bowen J, Pheby D, Charlett A, McNulty C. Chronic Fatigue Syndrome: a survey of GPs' attitudes and knowledge. Fam Pract. 2005;22:389–93.PubMed

17.

Gilliam AG, National Institutes of Health. Epidemiological study of an epidemic, diagnosed as poliomyelitis, occurring among the personnel of the Los Angeles County General Hospital during the summer of 1934. Washington: US Government Printing Office; 1938.

18.

Wessely S. Old wine in new bottles: neurasthenia and 'ME'. Psychol Med. 1990;20:35–533.PubMed

19.

Jelinek JE. Benign encephalomyelitis. Lancet (London, England). 1956;271:494–5.

20.

Ramsay M. Postviral fatigue syndrome: The saga of royal free disease. London: Gower Medical; 1986.

21.

Tobi M, Morag A, Ravid Z, Chowers I, Feldman-Weiss V, Michaeli Y, et al. Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet (London, England). 1982;1:61–4.

22.

Behan PO, Behan WM, Bell EJ. The postviral fatigue syndrome–an analysis of the findings in 50 cases. J Infect. 1985;10:211–22.PubMed

23.

Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, Straus SE, et al. Chronic fatigue syndrome: a working case definition. Ann Intern Med. 1988;108:387–9.PubMed

24.

Carruthers BM, Vande SMI. Myalgic Encephalomyelitis/chronic fatigue syndrome: a clinical case definition and guidelines for medical practitioners. An overview of the canadian consensus document. The National Library of Canada. 2003. https://www.investinme.org/Documents/PDFdocuments/Canadian_ME_Overview_A4.pdf. Accessed 04 Jan 2019.

25.

Carruthers BM, van de Sande MI, De Meirleir KL, Klimas NG, Broderick G, Mitchell T, et al. Myalgic encephalomyelitis: International Consensus Criteria. J Intern Med. 2011;270:327–38.PubMedPubMedCentral

26.

World Health Organization. Manual of the international statistical classification of diseases, injuries, and causes of death. International classification of disease. WHO. 1969. https://apps.who.int/iris/handle/10665/70934. Accessed 03 Mar 2019.

27.

World Health Organization. ICD-10. 2016. https://icd.who.int/browse10/2016/en#/G90 G99. Accessed 16 Mar 2020.

28.

World Health Organization. ICD-10. 2019. https://icd.who.int/browse10/2019/en#/G93.3. Accessed 16 Mar 2020.

29.

White PD. A perspective on causation of the chronic fatigue syndrome by considering its nosology. J Eval Clin Pract. 2019;25:991–6.PubMed

30.

World Health Organization. ICD-11 for mortality and morbidity statistics: WHO; 2019. https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/569175314. Accessed 10 Oct 2019.

31.

Freud S. The Unconscious. 1915. http://dravni.co.il/wp-content/uploads/2014/01/Freud-S.-1915.-The-Unconscious.-.pdf. Accessed 16 Mar 2020.

32.

McEvedy CP, Beard AW. A controlled follow-up of cases involved in an epidemic of 'benign myalgic encephalomyelitis'. Brit J Psychiat. 1973;122:141–50.PubMed

33.

Siegel ZA, Brown A, Devendorf A, Collier J, Jason LA. A content analysis of chronic fatigue syndrome and myalgic encephalomyelitis in the news from 1987 to 2013. Chronic Illn. 2018;14:3–12.PubMed

34.

Castro-Marrero J, Faro M, Zaragozá MC, Aliste L, de Sevilla TF, Alegre J. Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain. BMC Public Health. 2019;19:840.PubMedPubMedCentral

35.

Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953–9.PubMed

36.

Reeves WC, Wagner D, Nisenbaum R, Jones JF, Gurbaxani B, Solomon L, et al. Chronic fatigue syndrome—a clinically empirical approach to its definition and study. BMC Med. 2005;3:19.PubMedPubMedCentral

37.

Jason L, Evans M, Porter N, Brown M, Brown A, Hunnell J, et al. The development of a revised Canadian myalgic encephalomyelitis chronic fatigue syndrome case definition. Am J Biochem Biotechnol. 2010;6:120–35.

38.

van der Meer JW, Lloyd AR. A controversial consensus--comment on article by Broderick et al. J Intern Med. 2012;271:29–31.PubMed

39.

Morris G, Maes M. Case definitions and diagnostic criteria for myalgic encephalomyelitis and chronic fatigue syndrome: from clinical-consensus to evidence-based case definitions. Neuro Endocrinol Lett. 2013;34:185–99.PubMed

40.

Maes M, Twisk FN, Johnson C. Myalgic Encephalomyelitis (ME), Chronic Fatigue Syndrome (CFS), and Chronic Fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res. 2012;200:754–60.PubMed

41.

Maes M. A new case definition of Neuro-Inflammatory and Oxidative Fatigue (NIOF), a neuroprogressive disorder, formerly known as chronic fatigue syndrome or Myalgic Encephalomyelitis: results of multivariate pattern recognition methods and external validation by neuro-immune biomarkers. Neuro Endocrinol Lett. 2015;36:320–9.PubMed

42.

Jason LA, Kot B, Sunnquist M, Brown A, Evans M, Jantke R, et al. Chronic fatigue syndrome and myalgic encephalomyelitis: toward an empirical case definition. Health Psychol Behav Med. 2015;3:82–93.PubMed

43.

Cortes Rivera M, Mastronardi C, Silva-Aldana CT, Arcos-Burgos M. Myalgic encephalomyelitis/chronic fatigue syndrome: a comprehensive review. Diagnostics (Basel). 2019;9(3):91.

44.

Holmes GP, Kaplan JE, Stewart JA, Hunt B, Pinsky PF, Schonberger LB. A cluster of patients with a chronic mononucleosis-like syndrome Is Epstein-Barr virus the cause? JAMA. 1987;257:2297–302.PubMed

45.

Hickie I, Davenport T, Wakefield D, Vollmer-Conna U, Cameron B, Vernon SD, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ (Clin Res ed). 2006;333:575.

46.

Filler K, Lyon D, Bennett J, McCain N, Elswick R, Lukkahatai N, et al. Association of mitochondrial dysfunction and fatigue: a review of the literature. BBA Clin. 2014;1:12–23.PubMedPubMedCentral

47.

Blomberg J, Gottfries CG, Elfaitouri A, Rizwan M, Rosen A. Infection elicited autoimmunity and myalgic encephalomyelitis/chronic fatigue syndrome: an explanatory model. Front Immunol. 2018;9:229.PubMedPubMedCentral

48.

Sotzny F, Blanco J, Capelli E, Castro-Marrero J, Steiner S, Murovska M, et al. Myalgic encephalomyelitis/chronic fatigue syndrome—Evidence for an autoimmune disease. Autoimmun Rev. 2018;17:601–9.PubMed

49.

Komaroff AL. Advances in understanding the pathophysiology of chronic fatigue syndrome. JAMA. 2019. https://doi.org/10.1001/jama.2019.8312.CrossRefPubMed

50.

Mueller C, Lin JC, Sheriff S, Maudsley AA, Younger JW. Evidence of widespread metabolite abnormalities in myalgic encephalomyelitis/chronic fatigue syndrome: assessment with whole-brain magnetic resonance spectroscopy. Brain Imaging Behav. 2020;14:562–72.PubMed

51.

Naviaux RK, Naviaux JC, Li K, Bright AT, Alaynick WA, Wang L, et al. Metabolic features of chronic fatigue syndrome. Proc Natl Acad Sci USA. 2016;113:5472–80.

52.

Montoya JG, Holmes TH, Anderson JN, Maecker HT, Rosenberg-Hasson Y, Valencia IJ, et al. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc Natl Acad Sci USA. 2017;114:7150–8.

53.

Unger ER, Lin JS, Tian H, Gurbaxani BM, Boneva RS, Jones JF. Methods of applying the 1994 case definition of chronic fatigue syndrome—impact on classification and observed illness characteristics. Popul Health Metr. 2016;14:5.PubMedPubMedCentral

54.

Wilson A, Hickie I, Hadzi-Pavlovic D, Wakefield D, Parker G, Straus SE, et al. What is chronic fatigue syndrome? Heterogeneity within an international multicentre study. Aust N Z J Psychiatry. 2001;35:520–7.PubMed

55.

Collin SM, Nikolaus S, Heron J, Knoop H, White PD, Crawley E. Chronic fatigue syndrome (CFS) symptom-based phenotypes in two clinical cohorts of adult patients in the UK and The Netherlands. J Psychosom Res. 2016;81:14–23.PubMed

56.

Coggon D, Martyn C, Palmer KT, Evanoff B. Assessing case definitions in the absence of a diagnostic gold standard. Int J Epidemiol. 2005;34:949–52.PubMed

57.

Jason LA, Sunnquist M, Kot B, Brown A. Unintended consequences of not specifying exclusionary illnesses for systemic exertion intolerance disease. Diagnostics. 2015;5:272–86.PubMedPubMedCentral

58.

Esfandyarpour R, Kashi A, Nemat-Gorgani M, Wilhelmy J, Davis RW. A nanoelectronics-blood-based diagnostic biomarker for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Proc Natl Acad Sci. 2019;116:10250–7.PubMedPubMedCentral

59.

Stevens S, Snell C, Stevens J, Keller B, VanNess JM. Cardiopulmonary exercise test methodology for assessing exertion intolerance in myalgic encephalomyelitis/chronic fatigue syndrome. Front Pediatr. 2018;6:242.PubMedPubMedCentral

60.

Dowsett EG, Ramsay AM, McCartney RA, Bell EJ. Myalgic encephalomyelitis–a persistent enteroviral infection? Postgrad Med J. 1990;66:526–30.PubMedPubMedCentral

61.

Ho-Yen DO. Patient management of post-viral fatigue syndrome. Br J Gen Pract. 1990;40:37–9.PubMedPubMedCentral

62.

Lloyd AR, Hickie I, Boughton CR, Spencer O, Wakefield D. Prevalence of chronic fatigue syndrome in an Australian population. Med J Aust. 1990;153:522–8.PubMed

63.

Sharpe MC, Archard LC, Banatvala JE, Borysiewicz LK, Clare AW, David A, et al. A report–chronic fatigue syndrome: guidelines for research. J R Soc Med. 1991;84:118–21.PubMedPubMedCentral

64.

Schluederberg A, Straus SE, Peterson P, Blumenthal S, Komaroff AL, Spring SB, NIH conference, et al. Chronic fatigue syndrome research. Definition and medical outcome assessment. Ann Intern Med. 1992;117:325–31.PubMed

65.

Dowsett EG, Goudsmit E, Macintyre A, Shepherd CB. London criteria for M.E. Report from the National Task Force on Chronic Fatigue Syndrome (CFS), Post Viral Fatigue Syndrome (PVFS), Myalgic Encephalomyelitis (ME). Westcare. 1994:96–8.

66.

Komaroff AL, Fagioli LR, Geiger AM, Doolittle TH, Lee J, Kornish RJ, et al. An examination of the working case definition of chronic fatigue syndrome. Am J Med. 1996;100:56–64.PubMed

67.

Hartz AJ, Kuhn EM, Levine PH. Characteristics of fatigued persons associated with features of chronic fatigue syndrome. J Chronic Fatigue Syndr. 1998;4:71–977.

68.

National Collaborating Centre for Primary Care. NICE clinical guideline 53. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management of cfs/me in adults and children. National Institute for Health and Clinical Excellence. 2007. www.nice.org.uk/guidance/cg53. Accessed 19 Mar 2019.

69.

Jason L, Ma K, PhD S. Toward an empirical case definition of CFS. J Soc Serv Res. 2007;34:43–544.

70.

Hyde BM. The Nightingale, Myalgic Encephalomyelitis (M.E.) Definition. The Nightingale Research Foundation 2007. https://www.nightingale.ca. Accessed 19 Mar 2019.

71.

Jones JF, Kohl KS, Ahmadipour N, Bleijenberg G, Buchwald D, Evengard B, et al. Fatigue: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine. 2007;25:5685–96.PubMed

72.

Jason LA, Brown A, Clyne E, Bartgis L, Evans M, Brown M. Contrasting case definitions for chronic fatigue syndrome, Myalgic Encephalomyelitis/chronic fatigue syndrome and myalgic encephalomyelitis. Eval Health Prof. 2012;35:280–304.PubMed

Title: Review of case definitions for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)
Authors: Eun-Jin Lim
Chang-Gue Son
Publication date: 01-12-2020
Publisher: BioMed Central
Keyword: Fatigue
Published in: Journal of Translational Medicine / Issue 1/2020
Electronic ISSN: 1479-5876
DOI: https://doi.org/10.1186/s12967-020-02455-0

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

STEP AAG HeroTeaserCollection image/© Tarek / Generated with AI / Stock.adobe.com, ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

At a glance: The STEP trials

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2020

The potential therapeutic effects of the gut microbiome manipulation by synbiotic containing-Lactobacillus plantarum on neuropsychological performance of diabetic rats

Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration

Epidemiological and clinical factors associated with post-exertional malaise severity in patients with myalgic encephalomyelitis/chronic fatigue syndrome

Identification of MiR-211-5p as a tumor suppressor by targeting ACSL4 in Hepatocellular Carcinoma

Serum interleukin-6 is an indicator for severity in 901 patients with SARS-CoV-2 infection: a cohort study

A new immune signature for survival prediction and immune checkpoint molecules in lung adenocarcinoma

Highlights from the ACC 2024 Congress

ACC 2024 Congress Coverage